17-羟孕酮己酸酯在既往早产史女性中的依从性与结局
这项回顾性队列研究纳入92例有自发性早产史、孕16-20周开始每周肌注17-羟孕酮己酸酯(17-OHPC)的单胎妊娠女性,评估门诊注射依从性(完成>80%计划注射)与母婴结局的关系。结果显示依从率仅41.3%,依从组与非依从组在<37、<35、<32周自发性早产率、分娩孕周、出生体重及新生儿综合患病率上均无显著差异。
要点
- 门诊17-OHPC注射依从率低,仅41.3%(38/92)完成>80%计划注射。
- 依从组与非依从组分娩孕周、出生体重及新生儿综合患病率无显著差异。
- 依从组年龄较大(30.8岁 vs 27.4岁,P=.002),其余基线可比。
核心结论
- 真实世界中门诊17-OHPC注射依从性欠佳,不足半数女性完成>80%计划注射。
- 依从17-OHPC与否与分娩孕周、出生体重及新生儿结局无显著差异。
研究设计与样本
- 回顾性队列研究,纳入2014-2017年分娩、>18岁、单胎、有自发性早产史、孕16-20周开始每周17-OHPC门诊注射的女性,共92例。
主要发现
- 依从组与非依从组年龄分别为30.8岁与27.4岁(P=.002)。
- <37、<35、<32周自发性早产率两组无显著差异。
- 分娩孕周依从组36.8±2.6周 vs 非依从组36.5±3.8周(P=.66)。
- 出生体重依从组2776 g vs 非依从组2709 g(P=.68);新生儿综合患病率18.4% vs 20.4%(P=.86);NICU住院天数15.5天 vs 15天(P=.72)。
关键数值与推荐
- 依从性定义为完成>80%计划注射。
- 统计学显著性阈值P<.05。
临床怎么用
- 应关注门诊17-OHPC注射的依从性管理,但本研究未显示依从性与结局改善相关。
- 临床决策需结合个体情况,不宜仅依据依从性判断疗效。
局限性
- 回顾性设计、样本量小(92例)、单中心门诊人群,外推性受限。
- 排除在院外接受注射的女性,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Progesterone has been used for preventing preterm birth with mixed results. The American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine recommended the use of 17-hydroxyprogesterone caproate for risk reduction of recurrent spontaneous preterm birth based on the results of a multicenter, randomized trial in the United States. However, recent literature lacks consensus for efficacy in the American population. In addition, partial adherence and outcomes thereof are underreported. Hence, the relationship between practical adherence to 17-hydroxyprogesterone caproate and outcomes were evaluated. OBJECTIVE: The objective of this study was to evaluate the adherence to 17-hydroxyprogesterone caproate, defined as receipt of greater than 80% of intended injections, at an outpatient maternal-fetal medicine center and its effect on maternal and neonatal outcomes. STUDY DESIGN: This retrospective cohort study included women older than 18 years with a singleton gestation, history of spontaneous preterm birth who initiated 17-hydroxyprogesterone caproate weekly injections between 16 and 20 weeks' gestational age and delivered between the years 2014 and 2017. Women receiving 17-hydroxyprogesterone caproate injections outside of the clinic were excluded. The primary outcome of adherence and secondary outcomes of gestational age at delivery, birthweight, and neonatal outcomes were analyzed using descriptive data, independent t-test, Mann-Whitney U test, chi-square test, and Fisher exact test, where appropriate, with a P value <.05 being considered significant. RESULTS: Adherence to 17-hydroxyprogesterone caproate occurred in 38 of 92 (41.3%) women included in the study. At baseline, there was a difference in age between groups of adherent and nonadherent women (adherent: 30.8 years; nonadherent: 27.4 years; P=.002). The rate of spontaneous preterm birth less than 37, 35, and 32 weeks were not significantly different in those who were adherent vs nonadherent to 17-hydroxyprogesterone caproate. There were no differences in gestational age at delivery (adherent: 36.8±2.6 weeks; nonadherent: 36.5±3.8 weeks; P=.66), birthweight (adherent: 2776 g; nonadherent: 2709 g; P=.68), or composite neonatal morbidity (adherent: 18.4%; nonadherent: 20.4%; P=.86) between the adherent and nonadherent groups. Neonatal intensive care unit length of stay was 15.5 days in the adherent group compared with 15 days in the nonadherent group (P=.72). CONCLUSION: Real-world adherence to 17-hydroxyprogesterone caproate is suboptimal with less than half of women adherent to in-clinic administration. Adherence to 17-hydroxyprogesterone caproate was not associated with a difference in gestational age at delivery or birthweight compared with nonadherence. Further studies are needed to assess the outpatient administration and benefit of 17-hydroxyprogesterone caproate therapy.
引用
- Edwards AM, Lowry SA, Mikovich S, et al. Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth. Am J Obstet Gynecol MFM. 2020. PMID: 33345885. doi:10.1016/j.ajogmf.2020.100166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。